Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) dropped 0.6% during trading on Thursday . The company traded as low as $15.94 and last traded at $16.01. Approximately 1,980,480 shares traded hands during trading, a decline of 85% from the average daily volume of 12,980,435 shares. The stock had previously closed at $16.11.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on WBA shares. SVB Leerink decreased their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a "market perform" rating for the company in a research report on Monday, March 18th. Bank of America lowered their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an "underperform" rating on the stock in a research report on Tuesday, March 26th. Truist Financial restated a "hold" rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. TD Cowen decreased their price target on Walgreens Boots Alliance from $37.00 to $35.00 and set a "buy" rating on the stock in a research note on Wednesday, April 3rd. Finally, Evercore ISI cut their price objective on Walgreens Boots Alliance from $18.00 to $17.00 and set an "in-line" rating for the company in a report on Monday, June 3rd. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance currently has a consensus rating of "Hold" and a consensus price target of $23.57.
Check Out Our Latest Analysis on Walgreens Boots Alliance
Walgreens Boots Alliance Price Performance
The company's fifty day moving average is $16.87 and its two-hundred day moving average is $20.50. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $13.69 billion, a price-to-earnings ratio of -2.27, a price-to-earnings-growth ratio of 1.00 and a beta of 0.78.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.16 earnings per share. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current fiscal year.
Walgreens Boots Alliance Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 6.30%. The ex-dividend date of this dividend was Monday, May 20th. Walgreens Boots Alliance's dividend payout ratio is currently -14.29%.
Insider Activity at Walgreens Boots Alliance
In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the business's stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company's stock, valued at approximately $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the firm's stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company's stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of the business's stock in a transaction on Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company's stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.
Hedge Funds Weigh In On Walgreens Boots Alliance
A number of institutional investors have recently modified their holdings of the business. Highlander Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $26,000. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Venturi Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator's stock worth $28,000 after acquiring an additional 981 shares in the last quarter. Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at about $30,000. Finally, Quest Partners LLC bought a new stake in Walgreens Boots Alliance in the 4th quarter worth about $30,000. Institutional investors and hedge funds own 58.59% of the company's stock.
Walgreens Boots Alliance Company Profile
(Get Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Further Reading
- Five stocks we like better than Walgreens Boots Alliance
- What Are Dividend Achievers? An Introduction
- Darden Stock Up After Q4 Earnings Beat, Cautious FY25 Outlook
- How to Calculate Inflation Rate
- Celsius Stock: Why Piper Sandler Forecasts a 50% Surge
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Accenture’s Stock Earnings Reveal an AI-Powered Growth Strategy
→ A new cancer treatment conceived to do what no other cancer treatments can (From Starpax) (Ad)
Should you invest $1,000 in Walgreens Boots Alliance right now?
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
